James Meyer, Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc., filed a Statement of Changes in Beneficial Ownership on September 1, 2026, reporting five dispositions of common stock and a small indirect acquisition through the company's 401(k) plan, all dated August 28, 2026.

Key Highlights

  • Reporting person and role: James Meyer, Sr. Vice President and CFO of Thermo Fisher Scientific Inc. (NYSE:TMO), filed the disclosure.
  • Transaction code F: Five separate dispositions of common stock were recorded on August 28, 2026, each coded "F," at a price of $622.18 per share.
  • Shares disposed: The five transactions covered 37.23, 44.483, 19.824, 55.12, and 113.623 shares, respectively, for a combined total of 270.28 shares.
  • Remaining direct ownership: Following all reported transactions, Meyer directly held 5,559.758 shares of common stock.
  • Indirect 401(k) holding: Meyer also holds 58.47 shares indirectly through the TMO 401(k) plan, including 0.10 shares acquired between August 21, 2026, and August 28, 2026.
  • Signing authority: The form was signed by Melodie T. Morin as Attorney-in-Fact for James Meyer on September 1, 2026.

Details of Meyer's August 2026 Stock Activity at Thermo Fisher Scientific

According to the filing, all five dispositions were executed on August 28, 2026, under transaction code "F," which typically denotes shares withheld by the issuer to satisfy a tax obligation in connection with a vesting or exercise event, though the filing does not elaborate on the underlying equity award. Each transaction was recorded at a uniform price of $622.18 per share. The shares disposed were 37.23, 44.483, 19.824, 55.12, and 113.623, with the cumulative direct beneficial ownership declining from a pre-transaction level to 5,559.758 shares after the final transaction, as stated in the filing.

Thermo Fisher Scientific, traded on the New York Stock Exchange under the symbol TMO, is a life sciences and laboratory services company. Meyer serves as the company's Senior Vice President and Chief Financial Officer, making him an officer reporting person under Section 16(a) of the Securities Exchange Act of 1934. In addition to his directly held shares, the filing separately reports 58.47 shares held indirectly through the TMO 401(k) plan. The footnote to the filing states that between August 21, 2026, and August 28, 2026, Meyer acquired 0.10 shares of TMO common stock through that plan. No derivative securities transactions were reported in Table II of this filing.

What Was Disclosed

The filing discloses five share dispositions by Thermo Fisher Scientific's CFO on August 28, 2026, each at $622.18 per share, reducing his direct holdings to 5,559.758 shares, alongside a minor 401(k) plan acquisition of 0.10 shares over the same period.